InvestorsHub Logo
Followers 1
Posts 97
Boards Moderated 0
Alias Born 03/24/2009

Re: None

Wednesday, 06/04/2014 11:07:40 AM

Wednesday, June 04, 2014 11:07:40 AM

Post# of 8023
Aastrom CEO...."The acquisition of Sanofi's CTRM business is a transformative transaction that positions Aastrom as a fully-integrated global regenerative medicine company," said Nick Colangelo, president and chief executive officer of Aastrom. "The CTRM business brings us global manufacturing, marketing and sales capabilities that are structured to support the current portfolio of marketed products as well as our future product development plans. This transaction also provides us with a platform to generate operating income to support the development of our high-potential pipeline products and continued growth through additional strategic transactions."
.......when announced the aquisition Stock price 6.90

.......completion of aquisition, stock price 4.16, what am I missing for a 40% drop?

Dont tell me stocks aren't manipulated
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News